Skip to content

transpulmonary pressure guided ventilation in ARDS

COMPARATIVE EVALUATION OF TRANSPULMONARY PRESSURE GUIDED VENTILATION VERSUS CONVENTIONAL VENTILATION IN PATIENTS WITH A.R.D.S

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/032431
Enrollment
100
Registered
2021-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J99- Respiratory disorders in diseasesclassified elsewhere

Interventions

Intervention1: transpulmonary presssure measurement: While undergoing treatment, the subjects will be supine, with the head of the bed elevated to 30 degrees. Airway pressure, tidal volumes and other

Sponsors

self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients will be included in the study if they have moderate-to-severe ARDS according to the American-European Consensus Conference definitions. Duration of ARDS 36 hours or less from meeting final Berlin criterion Age more than 18 years.

Exclusion criteria

Exclusion criteria: Received mechanical ventilation more than 96â??h. Recently treated for bleeding varices, stricture, haematemesis, esophageal trauma, recent esophageal surgery or other contraindication for nasogastric tube placement. History of lung or liver transplantation. Severe chronic liver disease (Child-Pugh Score >=12). Patients not committed to full support. Inability to get informed consent from the patient or surrogate. Use of rescue therapies prior to enrolment (including nitric oxide, ECMO, prone positioning) Evidence of active air leak from the lung (including bronchopleural fistula, pneumothorax, pneumomediastinum or air leak from existing chest tube).

Design outcomes

Primary

MeasureTime frame
Improvement in PaO2 /FiO2 ratio Improvement in static compliance VILI like spontaneous pneumothorax Improvement in CO2 exchangeTimepoint: outcomes measured at baseline, at 6 and 12 hours respectively.

Secondary

MeasureTime frame
noneTimepoint: none

Countries

India

Contacts

Public ContactDr M Ravi krishna

dayanand medical college and hospital

drplgautam@gmail.com9876331565

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026